文献速递神经免疫

大剂量脉冲糖皮质激素预防新诊断多发性硬化脊髓白质假性萎缩

High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis.
PubMed 文献 · Ann Neurol · 2025-06-24

结果显示,未用HDG者第一年脊髓体积下降显著大于第二年(-2.06% vs 0.83%,P=0.02),而HDG组无此差异;且第一年HDG组脊髓体积下降小于未用HDG组(-0.51% vs -2.06%,P=0.02),提示HDG可抑制DMT启动后的白质假性萎缩。

要点

  • HDG可抑制DMT启动后第一年的脊髓白质假性萎缩。
  • 未用HDG者第一年脊髓体积下降显著大于第二年。
  • HDG预处理或提高短期MRI试验的可行性。

核心结论

  • 基线MRI前使用HDG可抑制DMT启动后的中枢神经系统白质假性萎缩,以脊髓最明显。

主要发现

  • DMT/no-HDG组第一年脊髓体积下降大于第二年(-2.06% vs 0.83%,P=0.02)。
  • DMT-HDG组第一年与第二年脊髓体积下降无显著差异(-0.51% vs 0.66%,P=0.8)。
  • DMT/no-HDG组第一年脊髓体积下降大于DMT-HDG组(-2.06% vs -0.51%,P=0.02)。

临床怎么用

  • 在新诊断多发性硬化患者启动DMT前使用HDG可能减少脊髓假性萎缩,有助于提高MRI试验结果的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spinal cord (SC) atrophy correlates with and predicts the underlying progressive biology in active and non-active multiple sclerosis (MS), thereby providing a biomarker for clinical trials and patient management. Initiation of disease-modifying therapy (DMT) may be followed by early pronounced central nervous system (CNS) volume loss due to resolution of inflammation (pseudoatrophy) and confounding the interpretation of atrophy. High-dose glucocorticoids (HDGs) reduce inflammation and might therefore modify pseudoatrophy. METHODS: One hundred twenty-three newly diagnosed and DMT-naïve MS participants (relapsing-remitting, 70% female participants, median age = 36 years, Expanded Disability Status Scale [EDSS] 2.0) were followed for up to 3 years. Forty-two participants received HDG before baseline magnetic resonance imaging (MRI; DMT-HDG; median = 52 days, interquartile range [IQR] = 37-71), whereas 60 did not (DMT/no-HDG). Twenty-one participants remained untreated (no-DMT), and 102 started DMT after baseline MRI. SC total cervical cord cross-sectional area (TCA), gray matter area (GMA), and white matter area (WMA) and regional brain volumes were analyzed using mixed effects models. RESULTS: The DMT-HDG, DMT/no-HDG, and no-DMT groups had similar demographic, clinical, and radiological features. Pronounced SC pseudoatrophy was observed based on more year 1 versus year 2 volume loss for DMT/no-HDG (-2.06% vs. 0.83%; P = 0.02) but not DMT-HDG (-0.51% vs. 0.66%; P = 0.8) and more year 1 volume loss for DMT/no-HDG compared to DMT-HDG (-2.06% vs. 0.51%; P = 0.02). INTERPRETATION: HDG preceding baseline MRI suppresses CNS white matter (WM) pseudoatrophy after DMT initiation, most conspicuously for the SC. Suppression of pseudoatrophy with HDG may improve the fidelity of clinical trials and enhance the feasibility for short-term trials with SC and brain MRI outcomes in active MS by pretreatment with HDG. ANN NEUROL 2025;98:837-850.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Sacco S, Papinutto N, Schoeps VA, et al. High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis. Ann Neurol. 2025. PMID: 40552528. doi:10.1002/ana.27298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。